PIP-LISINOPRIL lisinopril (as dihydrate) 2.5mg tablet blister pack
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Patient Information leaflet
(PIL)
24-08-2020
Public Assessment Report
(PAR)
28-11-2017
Send request.
Active ingredient:
lisinopril dihydrate (Equivalent: lisinopril, Qty 2.5 mg)
Available from:
Ipca Pharma (Australia) Pty Ltd
INN (International Name):
Lisinopril dihydrate
Pharmaceutical form:
Tablet, uncoated
Composition:
Excipient Ingredients: calcium hydrogen phosphate dihydrate; magnesium stearate; mannitol; maize starch
Administration route:
Oral
Units in package:
84, 50, 10, 28, 14, 100, 30, 56
Prescription type:
(S4) Prescription Only Medicine
Therapeutic indications:
Hypertension: PIP-Lisinopril Tablets are indicated in the treatment of hypertension. It may be used alone or concomitantly with other classes of antihypertensive agents. Sufficient data have not been provided to support the use of lisinopril (as dihydrate) in severe hypertension or renovascular hypertension. Congestive heart failure: PIP-Lisinopril Tablets are also indicated in the treatment of heart failure. In such patients, it is recommended that PIP-lisinopril tablets be administered with a diuretic. Acute myocardial infarction: PIP-Lisinopril Tablets are indicated for the treatment of acute myocardial infarction in haemodynamically stable patients, defined as patients who are not in cardiogenic shock and who have a systolic blood pressure greater than 100 mmHg. PIP-Lisinopril Tablets may be initiated within 24 hours of an acute myocardial infarction.
Product summary:
Visual Identification: White to almost white, circular, biconvex, uncoated tablets with '2.5' debossing on one side and 'BL' debossing on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Authorization status:
Licence status A
Authorization date:
2013-08-02
Patient Information leaflet
PIP-LISINOPRIL
CONSUMER MEDICINE INFORMATION JUNE 2013VERSION 1.3
COMMERCIAL-IN-CONFIDENCE
1
Lisinopril dihydrate
WHAT IS IN THIS LEAFLET
THIS LEAFLET ANSWERS SOME COMMON QUESTIONS ABOUT PIP-LISINOPRIL. IT
DOES NOT
CONTAIN ALL THE AVAILABLE INFORMATION.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risks of you taking PIP-
LISINOPRIL against the benefits they expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE
. You may need to read it again.
WHAT PIP-LISINOPRIL IS USED FOR
PIP-LISINOPRIL
LOWERS HIGH BLOOD PRESSURE, WHICH DOCTORS CALL HYPERTENSION. IT IS
ALSO USED TO TREAT HEART FAILURE AND PATIENTS WHO HAVE JUST HAD A
HEART ATTACK.
HYPERTENSION:
Everyone has blood pressure. This pressure helps get your blood all
around your body.
Your blood pressure may be different at different times of the day,
depending on how busy
or worried you are. You have hypertension (high blood pressure) when
your blood pressure
stays higher than is needed, even when you are calm and relaxed.
There are usually no symptoms of hypertension. The only way of knowing
that you have
hypertension is to have your blood pressure checked on a regular
basis. If high blood
pressure is not treated it can lead to serious health problems. You
may feel fine and have no
symptoms, but eventually hypertension can cause stroke, heart disease
and kidney failure.
PIP-Lisinopril helps to lower your blood pressure.
HEART FAILURE:
Heart failure means that the heart muscle cannot pump blood strongly
enough to supply all
the blood needed throughout the body. Heart failure is not the same as
heart attack and does
not mean that the heart stops working.
Heart failure may start off with no symptoms, but as the condition
progresses, patients may
feel short of breath or may get tired easily after light physical
activity such as walking. Some
patients may wake up short of breath at night
Read the complete document
